On June 21, 2021, PMG Pharmascience Co., Ltd. (KOSDAQ:A073570) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,955 KRW | -1.34% | -1.83% | -15.33% |
20/03 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
18/03 | JW Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,28,800 KRW | -0.77% | -3.52% | 2.54B | ||
7,590 KRW | -1.30% | -5.24% | 2.9B | ||
5,040 KRW | +1.41% | -0.79% | 133M | ||
4,205 KRW | +2.31% | +2.94% | 283M | ||
1st Jan change | Capi. | |
---|---|---|
-15.33% | 156M | |
+18.04% | 43.07B | |
+16.92% | 21.51B | |
+18.99% | 15.19B | |
+19.27% | 14.44B | |
+56.12% | 13.12B | |
-10.73% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+4.00% | 4.73B |
- Stock Market
- Equities
- A096760 Stock
- News JW Holdings Corporation
- PMG Pharmascience Co., Ltd. announced that it has received KRW 15 billion in funding from Eugene Investment & Securities Co.,Ltd., JJ Assets Co., Ltd., Mirae Asset Securities Co., Ltd., JW Holdings Corporation, Kiwoom Securities Co., Ltd.